Morning bright light therapy improved mood and markers linked to the brain's waste-clearance system in young adults with early depressive symptoms. Digest

Early depressive symptoms often precede major depressive disorder, but preventive strategies that target underlying brain biology are scarce. In a randomized trial, researchers examined whether daily morning bright light exposure could reduce symptoms while altering brain imaging markers related to the glymphatic system, which moves cerebrospinal fluid through channels surrounding blood vessels in the brain to help clear metabolic waste.

You just missed this in your inbox

Every other week our Premium Members received this exact study plus Rhonda's practical commentary and 8+ other hand-picked papers.

Get the next issue →

The study followed 110 adults aged 18 to 28 who had persistent depressive symptoms but did not meet the full criteria for major depressive disorder. Participants used either a 5,000-lux light box (brightness of outdoor light on an overcast day) or a placebo device that emitted very dim light (less than 5 lux) for 30 minutes each morning for 8 weeks. Researchers measured depressive symptoms and anhedonia (reduced ability to feel pleasure) before and after the 8-week intervention.

• After 8 weeks, those using bright light showed greater reductions in depressive symptoms and larger improvements in anhedonia scores.
• Bright light increased an MRI-based marker linked to glymphatic-related fluid movement along spaces surrounding brain blood vessels. Other fluid-related measures associated with the glymphatic system did not show clear differences between groups.
• Resting-state brain scans showed more synchronized local activity in the left superior frontal gyrus after bright light therapy, while this pattern declined in the placebo group. Because this region helps regulate mood, it suggests bright light may influence mood-related brain activity.
• In a subgroup who provided blood samples, levels of the inflammatory signaling proteins IL-9 and TNF-β decreased after bright light treatment. However, these reductions were not clearly greater than placebo when directly compared.
• Exploratory analyses within the bright light group showed that larger increases in the MRI measure linked to fluid movement were associated with greater improvements in anhedonia, more synchronized brain activity, and changes in inflammatory markers.

The activity of the glymphatic system increases during sleep and may be influenced by circadian rhythms, the internal 24-hour clock that governs sleep–wake timing. Morning light is a major signal that helps align this clock. When circadian timing is stable, sleep tends to be more regular and restorative, which may support the glymphatic system. Efficient waste clearance and stable sleep have been linked to healthy brain activity and balanced inflammatory signaling. By reinforcing circadian timing, bright morning light exposure may help reduce depressive symptoms.

The study relied on indirect imaging markers, a limited immune panel, and a narrow young adult sample without long-term follow-up. If future studies in broader populations confirm these results, morning bright light therapy could offer a low-risk way to support both mood and underlying brain processes during the earliest stages of depression. In this clip, I describe the connection between sleep, the glymphatic system, and dementia risk.